Vaccine Design and Testing – News and Features

A novel hydrogel therapy could be a first line of defense against viruses and other biological threats.

A novel vaccination strategy utilizing small interfering RNA molecules could protect infants from COVID-19 and flu with a single shot. The study suggests that the vaccine strategy could offer continued protection even if the virus mutates.

Scientists at St. Jude Children’s Research Hospital have shown that improving metabolic health in obese mice before vaccination, but not after, protects against influenza virus.

Last month a story about a 62-year-old male made headlines after he claimed to have received 217 vaccines against SARS-CoV-2. Scientists invited the individual for tests to investigate what happens in the body of a hypervaccinated individual.

In this interview, Erik Digman Wiklund tells us about the discovery of circRNA and discusses some of the challenges of harnessing its full potential for therapeutic interventions.

Language models can be used to home in on partial genome sequences and optimize those sequences to study biology and improve medicine, and have designed more effective mRNA vaccines.

New Phase 1 data from Memorial Sloan Kettering Cancer Center shows an investigational cancer vaccine may elicit lasting immune response in patients with pancreatic cancer.

A second-generation melanoma vaccine improves long-term survival, particularly for men, a new study shows.

The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; however, annually updating those boosters for specific SARS-CoV-2 variants is inefficient for scientists and patients.

By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.